Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator - PubMed (original) (raw)
Review
. 1995 Oct;44(10):1139-46.
doi: 10.2337/diab.44.10.1139.
Affiliations
- PMID: 7556948
- DOI: 10.2337/diab.44.10.1139
Review
Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator
K Sharma et al. Diabetes. 1995 Oct.
Abstract
Renal cells are a rich source of transforming growth factor (TGF)-beta, and they serve as targets for its actions. Our hypothesis that activation of the TGF-beta system in the kidney is implicated in the development of diabetic renal disease stems from the close similarity of actions of TGF-beta and high ambient glucose on renal cell growth and extracellular matrix metabolism. Proximal tubule cells and glomerular mesangial cells cultured in high glucose concentration express increased TGF-beta 1 mRNA and protein levels, and treatment with anti-TGF-beta antibodies results in prevention of the effects of high glucose to induce cellular hypertrophy and stimulate collagen biosynthesis. Several in vivo studies by different groups of investigators have reported overexpression of TGF-beta in the glomeruli in human and experimental diabetes. We have also observed that the development of renal hypertrophy in the insulin-dependent diabetic BB rat and NOD mouse is associated with increased expression of TGF-beta 1 in the kidney and that short-term administration of antibodies capable of neutralizing the activity of TGF-beta in the streptozotocin mouse model of diabetes results in attenuation of whole kidney and glomerular hypertrophy and overexpression of mRNAs encoding matrix components. Together, these findings are consistent with the hypothesis that the diabetic state stimulates TGF-beta expression in the kidney and that in turn this growth factor may mediate, in an autocrine/paracrine manner, some of the principal early manifestations of diabetic renal disease.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Role of transforming growth factor beta in diabetic nephropathy.
Ziyadeh FN. Ziyadeh FN. Exp Nephrol. 1994 Mar-Apr;2(2):137. Exp Nephrol. 1994. PMID: 8082013 No abstract available. - Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse.
Sharma K, Ziyadeh FN. Sharma K, et al. Am J Physiol. 1994 Dec;267(6 Pt 2):F1094-01. doi: 10.1152/ajprenal.1994.267.6.F1094. Am J Physiol. 1994. PMID: 7810696 - The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. Chen S, et al. Ren Fail. 2001 May-Jul;23(3-4):471-81. doi: 10.1081/jdi-100104730. Ren Fail. 2001. PMID: 11499562 Review. - Potential role of TGF-beta in diabetic nephropathy.
Hoffman BB, Sharma K, Ziyadeh FN. Hoffman BB, et al. Miner Electrolyte Metab. 1998;24(2-3):190-6. doi: 10.1159/000057369. Miner Electrolyte Metab. 1998. PMID: 9525704 Review.
Cited by
- Integrating network pharmacology and experimental validation to decipher the pharmacological mechanism of DXXK in treating diabetic kidney injury.
Zhang C, Ji Z, Xu N, Yuan J, Zeng W, Wang Y, He Q, Dong J, Zhang X, Yang D, Jiang W, Yan Y, Shang W, Chu J, Chu Q. Zhang C, et al. Sci Rep. 2024 Sep 27;14(1):22319. doi: 10.1038/s41598-024-73642-y. Sci Rep. 2024. PMID: 39333622 Free PMC article. - Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
Zhang X, Zhang J, Ren Y, Sun R, Zhai X. Zhang X, et al. Front Endocrinol (Lausanne). 2024 Feb 22;15:1368481. doi: 10.3389/fendo.2024.1368481. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38455648 Free PMC article. - Non-reducing End of Heparin Tri-saccharide is a Scavenger Tool to Detoxify the Glucose Toxicity in Diabetes.
Wang AJ, Wang A, Hascall VC. Wang AJ, et al. J Cell Immunol. 2023;5(3):82-86. doi: 10.33696/immunology.5.171. J Cell Immunol. 2023. PMID: 37885773 Free PMC article. - The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy.
Szostak J, Gorący A, Durys D, Dec P, Modrzejewski A, Pawlik A. Szostak J, et al. Int J Mol Sci. 2023 Mar 25;24(7):6214. doi: 10.3390/ijms24076214. Int J Mol Sci. 2023. PMID: 37047185 Free PMC article. Review. - The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease.
Kourtidou C, Tziomalos K. Kourtidou C, et al. Int J Mol Sci. 2023 Mar 22;24(6):6007. doi: 10.3390/ijms24066007. Int J Mol Sci. 2023. PMID: 36983082 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical